comparemela.com

Page 14 - International Investor Relations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TELUS International will release third quarter 2022 results and host an investor call on November 4

VANCOUVER, British Columbia TELUS International (NYSE and TSX: TIXT) will release its third quarter 2022 results on November 4, 2022, before the North…

ITURAN LOCATION AND CONTROL LTD ANNOUNCES DISTRIBUTION OF A $3 MILLION DIVIDEND

Captor Therapeutics Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma

10.08.2022 - WROCŁAW, Poland, Aug. 10, 2022 (GLOBE NEWSWIRE) - Captor Therapeutics S.A. (WSE:CTX), a biopharmaceutical company dedicated to the development of Targeted Protein Degradation (TPD)-based drugs for the treatment of cancer and autoimmune diseases, .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.